BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22026133)

  • 21. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
    Pisters KM; Vallières E; Crowley JJ; Franklin WA; Bunn PA; Ginsberg RJ; Putnam JB; Chansky K; Gandara D
    J Clin Oncol; 2010 Apr; 28(11):1843-9. PubMed ID: 20231678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Liver Transplantation.
    Takagi K; Yagi T; Shinoura S; Umeda Y; Yoshida R; Nobuoka D; Watanabe N; Kuise T; Fuji T; Araki H; Fujiwara T
    Acta Med Okayama; 2017 Feb; 71(1):85-89. PubMed ID: 28238015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lung adenocarcinoma with multiple pulmonary metastases completely responsive to combination chemotherapy with carboplatin and weekly paclitaxel--a case report].
    Ishida T; Tomiyasu M; Kohso H; Iwanami T; Ikegami T; Okazaki J; Emi Y; Kido A; Ezaki T
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1313-6. PubMed ID: 14518412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syndrome of inappropriate anti-diuretic hormone secretion secondary to carboplatin after docetaxel-carboplatin-trastuzumab combination for early stage HER-2 positive breast cancer.
    Turner N; Stewart J; Barnett F; White S
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):e9-e11. PubMed ID: 22897880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Marked improvement of Lambert-Eaton myasthenic syndrome resulting from treatment for small cell lung carcinoma].
    Honoki H; Kawagishi Y; Oda H; Miwa T; Inomata M; Fujita T; Matsui S; Kashii T; Maruyama M; Kobayashi M
    Nihon Kokyuki Gakkai Zasshi; 2003 May; 41(5):331-5. PubMed ID: 12822423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic hyponatremia due to inappropriate secretion of antidiuretic hormone as the first sign of a small cell lung cancer in an elderly man.
    Kamoi K; Kurokawa I; Kasai H; Mizusawa A; Ebe T; Sasaki H; Matuzuki Y; Seino Y; Takahashi M; Togashi K; Miyamura H; Sato Y; Takato H; Kaneko H
    Intern Med; 1998 Nov; 37(11):950-4. PubMed ID: 9868958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer.
    List AF; Hainsworth JD; Davis BW; Hande KR; Greco FA; Johnson DH
    J Clin Oncol; 1986 Aug; 4(8):1191-8. PubMed ID: 3016206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two Cases of Lung Stage ⅢSquamous Cell Carcinoma Treated with Carboplatin (CBDCA)plus Nab-Paclitaxel(Nab-PTX)].
    Yoshino Y; Miyagi J; Toume R; Naha Y; Uchihara T; Akamine M; Nakazato H; Kawakami M; Tomori T; Nagayoshi S; Nagamine S; Tomiyama T; Ohmine Y; Sasaki H; Ishikawa M; Maeshiro K
    Gan To Kagaku Ryoho; 2019 Jul; 46(7):1171-1173. PubMed ID: 31296824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant carboplatin-based chemotherapy in resected stage IIIA-N2 non-small cell lung cancer.
    Ou W; Sun HB; Ye X; Zhang BB; Yang H; Fang Q; Li P; Wang SY
    J Thorac Oncol; 2010 Jul; 5(7):1033-41. PubMed ID: 20502361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
    Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
    Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility study of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected non-small-cell lung cancer: FAST-nab.
    Saji H; Marushima H; Miyazawa T; Sakai H; Kimura H; Kurimoto N; Nakamura H
    Anticancer Drugs; 2017 Aug; 28(7):795-800. PubMed ID: 28538017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    Choong NW; Vokes EE; Haraf DJ; Tothy PK; Ferguson MK; Kasza K; Rudin CM; Hoffman PC; Krauss SA; Szeto L; Mauer AM
    J Thorac Oncol; 2008 Jan; 3(1):59-67. PubMed ID: 18166842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of syndrome of inappropriate secretion of antidiuretic hormone during progression of metastatic breast cancer.
    Andersen MK; Sørensen JB
    Acta Oncol; 1997; 36(5):535-7. PubMed ID: 9292753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Estimation of preoperative induction chemoradiotherapy effectiveness for non small-cell lung cancer].
    Sanada H; Hayashi A; Tomimitsu S; Ikeda K; Nakanishi K; Hiyama J; Hidaka D; Sawamoto R; Miyagawa Y; Misumi Y; Fujii A; Nakatsubo S; Tsuru M; Omagari J; Koshizuka H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2012-5. PubMed ID: 20037308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of endobronchial squamous cell lung cancer successfully treated with weekly chemotherapy of carboplatin and paclitaxel].
    Kambayashi T; Ri M; Yanagihara K; Miyahara R; Bando T; Hasegawa S; Inui K; Wada H
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):841-4. PubMed ID: 12852353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy].
    Baba Y; Harada H; Shimada S; Sasaki Y; Murai S; Abe M; Fujiwara S; Arai N; Kawaguchi Y; Kabasawa N; Tsukamoto H; Uto Y; Ariizumi H; Yanagisawa K; Hattori N; Saito B; Nakamaki T
    Rinsho Ketsueki; 2018; 59(11):2423-2427. PubMed ID: 30531137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Syndrome of inappropriate secretion of antidiuretic hormone suddenly occurring in a case following chemotherapy].
    Yamamoto Y; Kokubo A; Yonekawa M; Nakanishi K
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):107-9. PubMed ID: 15675594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.